Drug sensitivity (MTT) assay

SA Sanjay Awasthi
SS Sharad S. Singhal
JS Jyotsana Singhal
LN Lokesh Nagaprashantha
HL Hongzhi Li
YY Yate-Ching Yuan
ZL Zheng Liu
DB David Berz
HI Henry Igid
WG William C. Green
LT Lukman Tijani
VT Vijay Tonk
AR Aditya Rajan
YA Yogesh Awasthi
SS Sharda P. Singh
request Request a Protocol
ask Ask a question
Favorite

Cell density measurements were performed using a hemacytometer to count intact cells resistant to staining with trypan blue. Approximately 20,000 cells were plated into each well of 96-well flat-bottomed micro-titer plates. After 12 h incubation at 37°C, medium containing either pre-immune IgG or anti-RLIP76 IgG (ranging 0–60 μg/mL final conc.) were added to cells followed by incubation for 24 h, then 2HF (ranging 0–200 μM) were added to cells. After 48 h incubation, 20 μL of 5 mg/mL MTT were introduced to each well and incubated for 2 h of exposure. The plates were centrifuged and the medium was decanted. Cells were dissolved in 100 μL DMSO with gentle shaking for 2 h at room temperature, followed by measurement of OD570 [41]. Eight replicate wells in each of three separate measurements. For GI50 determination of CDNB and 2HF ±CDNB in H358 cells, approximately 5,000 cells were plated as above in 96 well plate. After 12 h cells were treated with 0–15 μM CDNB or 0–150 μM 2HF and 1 μM CDNB+0–150 μM 2HF. After 48 h MTT assay was performed as described above.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A